Rationale and Design for the Peripartum Cardiomyopathy in Nigeria (PEACE) Registry

Kamilu Musa Karaye, Idris Y Mohammed, Okechukwu S Ogah, Basil N Okeahialam

Abstract


Background: Nigeria probably has the highest burden of Peripartum Cardiomyopathy (PPCM) in the world. The primary objective is to describe the burden, ventricular remodelling and outcomes (rehospitalisation rate, cardio-embolic events and survival) of PPCM in Nigeria. In the sub-studies, we aim to describe the relationship between selenium deficiency, oxidative stress and PPCM, the impact of sodium selenite supplementation on cardiac function in PPCM, and the prevalence of selenium deficiency and its relationship with cardiac function in apparently healthy pregnant women.

Methods: The main Registry and the first sub-study are prospective longitudinal studies, while the second sub-study is an open-label randomised trial. 36 study centres across Nigeria have been registered and 10 of them are already recruiting subjects. Patients will be recruited from June to December 2017 and followed up till December 2018. Serum selenium and glutathione peroxidase will be assayed at recruitment for consecutive PPCM patients with LV ejection fraction (LVEF) <45% at 6 months postpartum. 200 subjects with selenium deficiency will be randomised into treatment (Selenium Selenite 200µg tablets daily for 3 months) and control arms. In the second sub-study, 120 apparently healthy pregnant women will be recruited at 28-38 weeks of gestation and reviewed at 6-8 weeks postpartum, and their serum selenium and GPO levels will be measured at recruitment.

Conclusion: This will be the largest systematic evaluation of PPCM in Nigeria, and it is hoped that the information will assist in developing locally applicable treatment guidelines and policies for the disease.


Keywords


Peripartum Cardiomyopathy Registry; PEACE; Selenium; Nigeria

Full Text:

PDF

References


Virchow R. Sitzing der Berliner Geburtshilflisher Gersellskhalt, cited by Porak, C. De l'influence réciproque de la grossesse et des maladies du Coeur, thesis, Paris, 1880.

Porak C. De l'influence réciproque de la grossesse et des maladies du Coeur, thesis, Paris, 1880.

Gouley BA, McMillan TM, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am J Med Sci 1937; 19: 185–199

Hull E, Hidden E. Postpartal heart failure. South Med J 1938; 31: 265–270

Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971; 44: 964-968.

Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of Peripartum cardiomyopathy. Circulation 1971; 44: 1053-1061.

Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12(8): 767-778. doi: 10.1093/eurjhf/hfq120

Ferriere M, Sacrez A, Bouhour JB, et al. Cardiomyopathy in the peripartum period: current aspects. A multicenter study. 11 cases. Arch Mal Coeur Vaiss 1990; 83(10): 1563–1569.

Cénac A, Djibo A. Postpartum cardiac failure in Sudanese–Sahelian Africa: clinical prevalence in western Niger. Am J Trop Med Hyg 1998; 58: 319–323.

Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000; 283: 1183–1188.

Fett JD, Christie LG, Carraway RD, et al. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Proceed 2005; 80: 1602–1606

Desai D, Moodley J, Naidoo D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 1995; 25: 118–123.

Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 2006; 97: 1765-1768. DOI:10.1016/j.amjcard.2006.01.039

Karaye KM, Sa’idu H, Habib AG. Peripartum and other cardiomyopathies in a Nigerian adult population. Int J Cardiol 2011; 147(2): 342-343. DOI: 10.1016/j.ijcard.2011.01.004

Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368: 687-693. DOI: 10.1016/S0140-6736(06)69253-2

Abboud J, Murad Y, Chen-Scarabelli C, et al. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007; 12; 118(3): 295-303. DOI: 10.1016/j.ijcard.2006.08.005

Karaye KM, Sani MU. The Impact of Income on the Echocardiographic Pattern of Heart Diseases in Kano, Nigeria. Niger J Med 2008; 17(3): 350-355.

Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050–2055. DOI: 10.1161/01.CIR.0000162478.36652.7E

Keshan Disease Research Group of the Chinese Academy of Medical Sciences, Beijing. Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin Med J (Engl.) 1979; 92: 477–482.

Karaye KM, Yahaya IA, Lindmark K, et al. Serum Selenium and Ceruloplasmin in Nigerians with Peripartum Cardiomyopathy. Int J Mol Sci 2015; 16: 7644-7654. DOI: 10.3390/ijms16047644

Sheppard R, Hsich E, Damp J, et al. GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy. Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study. Circ Heart Fail 2016; 9:e002683. DOI: 10.1161/CIRCHEARTFAILURE.115.002683

Karaye KM, Lindmark K, Henein, MY. Left ventricular structure and function among sisters of peripartum cardiomyopathy patients. Int J Cardiol 2014; 182C: 34-35. DOI: 10.1016/j.ijcard.2014.12.102

Fillmore SJ, Parry EH. The evolution of peripartal heart failure in Zaria. Circulation 1977; 56: 1058-1061.

Wang GY, Zhou R, Sun S, et al. The difference between whole blood and hair selenium levels of inhabitants in the endemic and nonendemic areas of Keshan disease (author’s translation). Zhonghua Yu Fang Yi Xue Za Zhi 1979; 13: 204–206.

Loscalzo J. Keshan Disease, Selenium Deficiency, and the Selenoproteome. N Engl J Med 2014; 370 (18): 1756-1760. doi: 10.1056/NEJMcibr1402199.

Beck MA, Levander OA, Handy J. Selenium deficiency and viral infection. J Nutr 2003; 133: Suppl 1:1463S-1467S.

Fett JD, Ansari AA, Sundstrom JB, et al. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 2002; 86: 311–316.

Asemi Z, Jamilian M, Mesdaghinia E, et al. Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Nutrition 2015; 31(10): 1235-1242. doi: 10.1016/j.nut.2015.04.014.

Mesdaghinia E, Rahavi A, Bahmani F, et al. Clinical and Metabolic Response to Selenium Supplementation in Pregnant Women at Risk for Intrauterine Growth Restriction: Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res 2017; 178(1): 14-21. doi: 10.1007/s12011-016-0911-0.

Ruys TP, Roos-Hesselink JW, Hall R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart 2014; 100: 231–238. doi: 10.1136/heartjnl-2013-304888.

Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation 2016; 133: 1397-1409. doi: 10.1161/CIRCULATIONAHA.115.020491.

Melchiorre K, Sharma R, Khalil A, et al. Maternal cardiovascular function in pregnancy. Evidence of maladaptation to chronic volume overload. Hypertension 2016; 67: 754-762. doi: 10.1161/HYPERTENSIONAHA.115.06667.

Blauwet LA, Libhaber E, Forster O, et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart 2013; 99(5): 308-313. doi: 10.1136/heartjnl-2012-302760.

Fett JD, Christie LG, Carraway RD, et al. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005; 80(12): 1602-1606. DOI: 10.4065/80.12.1602.

Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: an omnious diagnosis. Am J Obstet Gynecol 1997; 176: 182–188.

Karaye KM, Lindmark K, Henein MY. One year survival in Nigerians with peripartum cardiomyopathy. Heart Views 2016; 17: 55-61. doi: 10.4103/1995-705X.185114.

Karaye KM, Lindmark K, Henein MY. Right ventricular systolic dysfunction and remodelling in Nigerians with peripartum cardiomyopathy: a longitudinal study. BMC Cardiovasc Disord 2016; 16: 27. doi: 10.1186/s12872-016-0204-8.

Merlo M, Pyxaras SA, Pinamonti B, et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011; 57(13): 1468-76. doi: 10.1016/j.jacc.2010.11.030.

Karaye KM, Lindmark K, Henein MY. Electrocardiographic predictors of peripartum cardiomyopathy. Cardiovasc J Afr 2016; 27(2): 66-70. doi: 10.5830/CVJA-2015-092.

Karaye KM. Right ventricular systolic function in peripartum and dilated cardiomyopathies. Eur J Echocardiogr 2011; 12(5): 372-374. doi: 10.1093/ejechocard/jer024.

Blauwet LA, Delgado-Montero A, Ryo K, et al; IPAC Investigators. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes. Circ Heart Fail 2016; 9(5): pii: e002756. doi: 10.1161/CIRCHEARTFAILURE.115.002756

Karaye KM, Lindmark K, Henein, MY. Prevalence and predictors of right ventricular diastolic dysfunction in peripartum cardiomyopathy. J Echocardiogr 2017. DOI: 10.1007/s12574-017-0333-9

Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933–989. doi: 10.1016/j.ejheart.2008.08.005.

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28(1): 1-39. doi: 10.1016/j.echo.2014.10.003.

Kadish AH, Buxton AE, Kennedy HL, et al. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: a report of the American College of Cardiology/American Heart Association/ American College of Physicians − American Society of Internal Medicine Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography). J Am Coll Cardiol 2001; 38: 2091−2100.

Lefevre G, Bonneau C, Rahma S, et al. Determination of plasma protein-bound malondialdehyde by derivative spectrophotometry. Eur J Clin Chem Clin Biochem 1996; 34: 631-636.

Marklund SL, Holme E, Hellner L. Superoxide dismutase in extracellular fluids. Clinica Chimica Acta 1982; 126: 41-51

Wheeler CR, Salzman JA, Elsayed NM, et al. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 1990; 184(2): 193-199

World Medical Association Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. J Postgrad Med 2002; 48: 206-208.

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015; 2:2. DOI: 10.17987/icfj.v2i1.4.




DOI: https://doi.org/10.17987/icfj.v12i0.462

Comments on this article

View all comments


Copyright (c) 2017 The Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.